AG
CBIO
Artal Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,589,064
| Closed | -$2.42M | – | 38 |
|
|
2024
Q2 | $2.42M | Hold |
8,589,064
| – | – | 0.06% | 73 |
|
|
2024
Q1 | $25.8M | Hold |
8,589,064
| – | – | 0.66% | 21 |
|
|
2023
Q4 | $20.3M | Hold |
8,589,064
| – | – | 0.67% | 19 |
|
|
2023
Q3 | $12.9M | Hold |
8,589,064
| – | – | 0.55% | 27 |
|
|
2023
Q2 | $14.9M | Hold |
8,589,064
| – | – | 0.46% | 31 |
|
|
2023
Q1 | $10.8M | Buy |
+8,589,064
| New | +$10.8M | 0.64% | 39 |
|
|
2018
Q3 | – | Sell |
-250,000
| Closed | -$4.03M | – | 94 |
|
|
2018
Q2 | $4.03M | Sell |
250,000
-75,000
| -23% | -$1.21M | 0.09% | 52 |
|
|
2018
Q1 | $5.28M | Buy |
325,000
+75,000
| +30% | +$1.22M | 0.07% | 41 |
|
|
2017
Q4 | $4.2M | Buy |
250,000
+47,500
| +23% | +$798K | 0.06% | 43 |
|
|
2017
Q3 | $2.83M | Hold |
202,500
| – | – | 0.05% | 54 |
|
|
2017
Q2 | $2.26M | Buy |
+202,500
| New | +$2.26M | 0.04% | 67 |
|